Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: ##STR00001## wherein R.sub.1 and R.sub.6 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.


< Mammalian IAP gene family, primers, probes, and detection methods

< Pharmaceutical compositions for treating bone lesions in multiple myeloma

> Human chemokine beta-10 mutant polypeptides

> Computer-based method for creating collections of sequences from a dataset of sequence identifiers corresponding to natural complex biopolymer sequences and linked to corresponding annotations

~ 00295